(1)
Study on the Possible Role of the -174G>C IL-6 Promoter Polymorphism in Predicting Response to Rituximab in Rheumatoid Arthritis. Reumatismo 2010, 62 (4), 253-258. https://doi.org/10.4081/reumatismo.2010.253.